Mindbloom vs Innerwell: The Full Comparison Guide

Mindbloom vs Innerwell at a Glance

Both Mindbloom and Innerwell are leading providers of at-home ketamine therapy for depression, anxiety, and PTSD. They differ significantly in their clinical frameworks, published evidence, administration options, and pricing.

This quick-reference table highlights the core differences before exploring each provider in detail.

What Is Mindbloom

Mindbloom is one of the largest providers of guided at-home ketamine therapy in the United States. The company delivers protocol-driven programs that pair clinician-prescribed ketamine with dedicated coaching, integration support, and an engaged community.

The Mindbloom care model is designed to provide a comprehensive therapeutic process rather than just medication delivery. Patients frequently highlight this comprehensive support system.

The experience includes several core components:

• Clinician oversight: Licensed psychiatric clinicians conduct a thorough intake evaluation, prescribe the medication, and manage dosing throughout the program.
• Guide coaching: Each client is paired with a dedicated guide for one-on-one preparation and integration sessions to help process the experience.
• Group Integration Circles: Clients receive unlimited access to guide-facilitated peer integration sessions to share insights and build community.
• Bloombox: A physical kit is shipped to the client containing a blood pressure monitor, journal, eye mask, and other session essentials.
• Mindbloom App: The proprietary Mindbloom app guides sessions with custom soundscapes, preparation content, and integration journaling.
• Administration options: Clients can choose between sublingual tablets and Mindbloom injectables, making it the only at-home provider offering subcutaneous administration.

Mindbloom has facilitated over 700,000 clinician-supervised sessions to date. Mindbloom has published two peer-reviewed studies evaluating the safety and effectiveness of its own protocol, helping answer the common question of whether the service is legitimate.

Ketamine has been FDA-approved as an anesthetic since 1970 and has been on the World Health Organization List of Essential Medicines since 1985. Mindbloom's model builds directly on this established clinical foundation.

Pros of Mindbloom:

• Comprehensive care model with clinician oversight, guide coaching, and community support
• Only at-home provider offering subcutaneous injectables for more consistent absorption
• Two peer-reviewed studies published on its specific clinical protocol
• Widely accessible in more than 35 states

Cons of Mindbloom:

• Higher per-program cost than some competitors
• Does not offer licensed talk therapy or EMDR directly
• No direct insurance billing, though HSA/FSA funds are eligible and a Superbill is provided for potential partial reimbursement

Mindbloom's six-session new client program is $430/month over three months ($1,290 total). Twelve- and eighteen-session programs are also available at lower per-session rates — as low as $330/month over 9 months for an 18-session program. Returning client programs of 6 or 18 sessions offer preferred pricing for continuing clients.

What Is Innerwell

Innerwell is an online ketamine treatment provider that combines sublingual ketamine therapy with access to licensed therapists. The company focuses on integrating traditional psychotherapy modalities with psychedelic medicine.

The Innerwell experience is built around flexibility and therapeutic integration. When looking at Innerwell reviews, clients often appreciate the ability to work directly with licensed mental health professionals.

The program includes the following elements:

• Clinical model: Clients undergo a psychiatric evaluation and receive prescription management via telehealth, with sublingual ketamine tablets shipped for at-home use.
• Therapy integration: Innerwell differentiates itself by offering licensed talk therapy and EMDR (Eye Movement Desensitization and Reprocessing) alongside ketamine treatment.
• Session structure: Programs typically include 8 or 24 sessions, providing flexibility for longer-term treatment plans.
• Dosing approach: Innerwell's dosing approach is clinician-guided and may begin conservatively, with adjustments based on the patient's response and overall clinical assessment.
• Availability: The service is available in 33 states.

Innerwell may appeal to individuals who specifically want licensed talk therapy or EMDR integrated directly into their ketamine treatment plan. The company does not currently offer subcutaneous administration or published outcomes data on its own clinical protocol.

Pros of Innerwell:

• Licensed talk therapy and EMDR available alongside ketamine sessions
• Lower cost per session compared to some other providers
• Accepts some insurance plans to help offset costs
• Flexible session counts with 8 or 24-session options

Cons of Innerwell:

• No published peer-reviewed research on its own specific protocol
• Sublingual tablets only, with no subcutaneous or injectable option available

Innerwell cost is generally around $924 to $998 for an eight-session program. For those using accepted insurance, the cost can be approximately $599, and 24-session plans are available for extended care.

Comparing Care Models for Mindbloom and Innerwell

A care model refers to the full framework of clinical oversight, therapeutic support, and integration that surrounds the ketamine sessions themselves. It encompasses everything from preparation to the post-session transition, ensuring the medication is part of a broader healing process.

Mindbloom's Guided Program Model

Mindbloom utilizes a highly supported, protocol-driven approach to care. Licensed clinicians handle evaluation, prescribing, and ongoing dosage management to ensure medical appropriateness.

Beyond the medical component, clients work with a dedicated guide for coaching sessions focused entirely on preparation and integration. Clients also gain unlimited access to Group Integration Circles for peer-supported processing.

During every session, a peer treatment monitor is required to be present to ensure safety and comfort. The entire journey is supported by the Mindbloom app, which provides additional tools such as custom soundscapes and journaling prompts.

Innerwell's Therapy Integrated Model

Innerwell utilizes a model that heavily emphasizes traditional psychotherapy. Psychiatric evaluation and prescription management are handled via telehealth, similar to other online providers.

The primary distinction is that licensed therapists are available for talk therapy and EMDR, rather than peer guides or coaches. Ketamine sessions are conducted at home using sublingual tablets, and the company positions itself as a bridge between conventional therapy and psychedelic medicine.

This model may suit clients who specifically want licensed therapy as their primary support mechanism during treatment. The right choice depends on whether you prioritize a defined treatment framework with community support or licensed talk therapy.

Administration Methods and Dosing Differences

Administration method refers to how ketamine is delivered into the body. The most common routes are sublingual (a tablet held in the mouth), subcutaneous (a small injection), intravenous (IV infusion), or intranasal.

Each route offers different bioavailability, onset times, and session characteristics. Bioavailability refers to the proportion of the medication that successfully enters your circulation and has an active effect.

Mindbloom offers two distinct administration routes to accommodate different patient needs:

• Sublingual tablets: These are held between the cheek and gums for seven minutes before the effects begin within 10 to 15 minutes. This needle-free option is convenient, though it comes with the tradeoff of somewhat variable absorption.
• Subcutaneous injectables: Administered via a small insulin needle into the abdomen, effects begin in about five minutes. This route offers higher bioavailability and more consistent session intensity.

Mindbloom is the only at-home provider offering this subcutaneous option. Innerwell currently offers sublingual tablets exclusively, with no injectable option available through their platform.

Both providers utilize clinician-determined, sub-anesthetic therapeutic dosing. Mindbloom personalizes the treatment frequency based on clinical guidance and individual response.

Innerwell describes a clinician-guided titration approach in which dosing is adjusted over time based on patient response and tolerability. If consistent session intensity matters to you, Mindbloom's subcutaneous option is a meaningful differentiator when comparing at-home ketamine vs infusion clinics.

Published Research and Clinical Evidence

Published research on a provider's own protocol means that peer-reviewed studies have evaluated outcomes specifically from that provider's patients. This research uses the exact clinical model the company employs, rather than relying on general ketamine research applied by association.

Mindbloom has published two of the largest peer-reviewed, real-world outcomes studies of at-home ketamine therapy to date. The first study, Hull et al. (2022), was published in the Journal of Affective Disorders and evaluated the safety and effectiveness of Mindbloom's sublingual ketamine protocol.

The second study, Mathai et al. (2024), also published in the Journal of Affective Disorders, represents the largest published study of at-home ketamine therapy outcomes to date. Additionally, Mindbloom has released a PTSD preprint (Swain et al., 2026) and a sleep white paper.

Innerwell does not currently have published peer-reviewed research evaluating outcomes from its own clinical protocol and often references Mindbloom's peer-reviewed studies to support its own safety and efficacy positioning. This does not mean Innerwell's treatment is ineffective, as ketamine's therapeutic evidence base is well-established across decades of research. However, it does mean that prospective patients cannot evaluate Innerwell-specific outcomes from independent, peer-reviewed data and should be aware that outcomes from one provider's protocol do not automatically transfer to another. Published protocol-specific research is one of the strongest signals of clinical accountability, allowing clients to evaluate real-world outcomes from the exact program they would enroll in.

Cost Insurance and Accessibility

Cost comparison for at-home ketamine therapy requires looking beyond the sticker price. A thorough evaluation should account for the per-session price, what is included in that price, and whether insurance or HSA/FSA funds can be applied.

Mindbloom's six-session new client program is $430/month over three months ($1,290 total), which includes 2 clinician consults, 6 sessions with medicine, 3 guide coaching sessions plus unlimited messaging, unlimited Group Integration Circles, the Bloombox, and full app access. Twelve-session ($370/month over 6 months) and eighteen-session ($330/month over 9 months) programs are also available at a lower per-session cost.

Returning client programs of 6 or 18 sessions are available at preferred rates for continuing clients. While Mindbloom does not bill insurance directly, all programs are HSA/FSA eligible, and clients receive a Superbill after completing treatment — an itemized receipt that can be submitted to their insurance provider for potential partial reimbursement.

Innerwell pricing is generally $924 to $998 for an eight-session program, which can drop to approximately $599 with insurance. They also offer 24-session plans at a lower per-session cost.

The fact that some insurance is accepted is a meaningful differentiator for cost-sensitive clients. However, applicable insurance coverage primarily applies to standard psychiatry or therapy visits — in most cases, the ketamine medication, dosing sessions, and program fees remain out-of-pocket. Meaningful insurance coverage is largely limited to select plans in certain states, and therapy sessions may be billed separately.

Mindbloom's per-program cost includes a broader set of services, such as guide coaching and integration circles, that Innerwell does not bundle in the same way. The comparison is not apples-to-apples without accounting for these included support systems.

Safety and Screening Protocols

Safety in at-home ketamine therapy is a function of clinical screening, defined treatment frameworks, ongoing oversight, and in-session monitoring. It is not determined by dose size or setting alone.

A robust safety protocol requires evaluating a patient's full medical and psychiatric history before treatment begins. This ensures the medication is medically appropriate and identifies any potential contraindications.

Mindbloom's safety protocols begin with comprehensive medical and psychiatric screening during the intake process. Dosing is clinician-supervised, with ongoing adjustments made based on the patient's response.

A peer treatment monitor is required to be present during every session to ensure a secure environment. Additionally, 24/7 live chat support is available for patients.

Innerwell's safety protocols also start with a thorough psychiatric evaluation during intake. Prescribing and dosing are managed by licensed clinicians, and the company recommends having a support person present during sessions.

Innerwell describes a clinician-guided titration approach in which dosing is adjusted over time based on patient response and tolerability. Both providers conduct rigorous medical screening and utilize clinician oversight to mitigate potential risks.

Mindbloom's published safety data provides a quantified, peer-reviewed safety profile that prospective clients can evaluate directly. As noted above, Innerwell does not currently have published protocol-specific safety data.

Mindbloom Outcomes What the Published Research Shows

Direct comparisons across treatment modalities should be interpreted with caution due to differences in study design, patient populations, and outcome measures. However, Mindbloom's published data provides specific insight into the effectiveness of its protocol.

In a peer-reviewed study of 11,441 patients using the PHQ-9 and GAD-7 instruments, 89% of participants reported improvement in their depression and anxiety symptoms. The data showed a 56.4% response rate for depression and a 56.1% response rate for anxiety.

Mindbloom's reported depression response rates exceed those reported in selected SSRI antidepressant studies (Stone M et al., 2022) and selected meta-analyses of talk therapy (Cuijpers P et al., 2021).

For PTSD, a real-world analysis of 374 program completers using the PCL-5 instrument demonstrated that 92.2% reported symptom improvement. The study also showed a 79.7% response rate and a 60.7% remission rate.

These reported outcomes exceed response rates reported in selected randomized trials of prolonged exposure therapy and sertraline for PTSD (Rauch SAM et al., 2019). Regarding safety, side effects were reported in approximately 4-5% of participants, and adverse events occurred in fewer than 0.1% of sessions.

For sleep, a retrospective analysis of 13,963 program completers found that 77% reported clinically meaningful improvements in sleep, with a 49% average improvement in sleep disturbances. Only 2.5% reported worsened sleep.

Individual results may vary, but these statistics reflect the exact program a prospective client would enroll in.

Which At Home Ketamine Program Is Right for You

Choosing between Innerwell vs Mindbloom depends entirely on your clinical needs, personal preferences, and financial circumstances. Both offer clinician-led at-home ketamine care models, but the most appropriate option depends on a person's clinical needs, preferences, and treatment goals.

Mindbloom may be right for you if:

• You want a clinically managed experience with built-in coaching and integration.
• Published, peer-reviewed outcomes data on the specific program you will enroll in matters to you.
• You want the option of subcutaneous administration for more consistent sessions.
• You value community support through Group Integration Circles.
• You are located in one of the 35+ states where Mindbloom operates.

Innerwell may be right for you if:

• You specifically want licensed talk therapy or EMDR integrated with ketamine treatment.
• Insurance coverage for ketamine therapy is a primary financial priority.
• You prefer a lower per-session cost.
• You are located in one of Innerwell's 33 available states.
• You prefer to start with lower doses and titrate gradually.

Disclaimer and Safety Information

IMPORTANT SAFETY INFORMATION
‍Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary.Full safety information: www.mindbloom.com/safety-information‍

‍OFF-LABEL USE DISCLOSURE
‍Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.